Biosyn other research news

Biosyn received an undisclosed amount of funding from the NIAID for further development of its Prevecon vaginal microbicide and spermicide. The synthetic, organic molecule is designed to prevent the transmission of sexually transmitted diseases, including HIV.

The grant is part of a $3 million program project grant with Pennsylvania State University and the University of North Carolina for development of the drug. Phase I studies have been completed in collaboration with NIAID and the National Institute for Child Health and Human Development. ...